Blood cells rejuvenated after a heart attack with new method

February 15, 2011, Netherlands Organisation for Scientific Research (NWO)

People who survive a heart attack live with a weakened heart muscle for the rest of their lives because the part of the heart affected by the heart attack dies and can no longer contribute to the heart's pump function. Injecting stem cells into the heart is a promising technique for repairing it. These stem cells are isolated from the blood. Unfortunately, those who experience a heart attack are often elderly people with a suboptimal health. Their stem cells may therefore be too weak to fix the heart.

Dutch researcher Reinier Boon discovered the Achilles' heel of cells that repair these . He found that it was a protein naturally occurring in blood vessels called KLF2. By increasing the amount of KLF2 in repair cells, so-called circulating pro-angiogenic cells (PACs), he was able to rejuvenate these cells. They could then be used to efficiently repair the heart.

Boon not only gave the PACs a boost, he was also able to increase the number of PACs in the blood. Elderly people and those in poor health often have far fewer PACs in the blood. Experiments in elderly mice revealed that the number of PACs in the blood normalized when the amount of KLF2 they contained was artificially returned to the level young healthy PACs contain. In these experiments, PACs containing more KLF2 were also better at repairing blood vessels. Now the next step is to find a method that allows us to safely increase the amount of KLF2 in the PACs of heart patients. Although rejuvenation with KLF2 improves the repair capacity of PACs, it remains uncertain whether this improvement is enough to guarantee full restoration of the heart. Boon’s method may make stem cell therapy more efficient.

Boon's results were published in the European Heart Journal of 1 February 2011. The research was carried out at the Institute of Cardiovascular Regeneration at Frankfurt University. So far, this method has only been demonstrated to work in mice, but the discovery will provide leads for further research into human treatments. Boon also discovered a microRNA important for the immediate repair process after a heart attack and a microRNA that plays a role in the development of aneurysms. These two discoveries also provide direction for further research into the recovery process following a .

Boon’s research was funded by NWO's Rubicon program. Rubicon allows scientists who have recently obtained a PhD to gain research experience in world-class institutes abroad.

Related Stories

Recommended for you

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

The HLF gene protects blood stem cells by maintaining them in a resting state

January 17, 2018
The HLF gene is necessary for maintaining blood stem cells in a resting state, which is crucial for ensuring normal blood production. This has been shown by a new research study from Lund University in Sweden published in ...

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.